
Our next generation digital telemedicine solutions enhance the quality and efficacy of medical care, allowing the healthcare staff to refocus on its original job – caring for the patient. The Tele-ICU team with one highly experienced intensivist can provide service for 100 or more ICU patients at any time by leveraging high quality telemedicine clinical decision support, made possible by predictive algorithms and artificial intelligence. Machine learning can enable the tele-ICU team to identify patterns in large data sets of high-frequency, real-time patient data (e.g. vital parameters, laboratory results, ventilator setup, etc.) to provide support that can range from detection of unintentional pharmaceutical interactions to prediction of deterioration and outcome of ICU patients. This transformation in ICU care will result in large medical competence centers providing this type of high-end telemedicine and will create new specialties such as “Telemedicine Specialist”. Again, telemedicine is not a competitor, but rather a supporter, of ICU performance optimization. Collaboration between centralized centers and bedside teams will lead to improved outcomes, shorter length of stay, decreased purchased care costs, and greater staff satisfaction. The Society of Critical Care recently recommended replacing the term “tele-ICU” with “tele-critical-care” due to the fact that existing tele-ICU providers have extended their service to other departments (e.g. emergency department, stroke unit), indicating fast adoption of telemedicine in broad applications. Furthermore, many medical smartphone apps exist, though quality and relevance varies greatly. As smartphones permeate modern daily life and routine, there is growing interest in utilizing them in telemedicine; however, at this point there is limited large-scale evaluation of this use.

Our next generation digital telemedicine solutions enhance the quality and efficacy of medical care, allowing the healthcare staff to refocus on its original job – caring for the patient. The Tele-ICU team with one highly experienced intensivist can provide service for 100 or more ICU patients at any time by leveraging high quality telemedicine clinical decision support, made possible by predictive algorithms and artificial intelligence. Machine learning can enable the tele-ICU team to identify patterns in large data sets of high-frequency, real-time patient data (e.g. vital parameters, laboratory results, ventilator setup, etc.) to provide support that can range from detection of unintentional pharmaceutical interactions to prediction of deterioration and outcome of ICU patients. This transformation in ICU care will result in large medical competence centers providing this type of high-end telemedicine and will create new specialties such as “Telemedicine Specialist”. Again, telemedicine is not a competitor, but rather a supporter, of ICU performance optimization. Collaboration between centralized centers and bedside teams will lead to improved outcomes, shorter length of stay, decreased purchased care costs, and greater staff satisfaction. The Society of Critical Care recently recommended replacing the term “tele-ICU” with “tele-critical-care” due to the fact that existing tele-ICU providers have extended their service to other departments (e.g. emergency department, stroke unit), indicating fast adoption of telemedicine in broad applications. Furthermore, many medical smartphone apps exist, though quality and relevance varies greatly. As smartphones permeate modern daily life and routine, there is growing interest in utilizing them in telemedicine; however, at this point there is limited large-scale evaluation of this use.
Core product: TCC Core — modular, AI-enabled telemedicine platform for hub-and-spoke hospital networks
Focus areas: Tele-ICU/tele-critical-care, real-time dashboards, clinical decision support
Founded: 2020
Headquarters: Hamburg, Germany
Reported funding stage: Series A (Nov 2024) — lead investor named
| Company |
|---|
Telemedicine for critical care and hospital network connectivity; real-time monitoring and AI-driven clinical decision support.
2020
Healthtech / Telemedicine
Public profiles report a Series A in Nov 2024 with a named lead investor; amounts not publicly disclosed in available profiles.
Dealroom lists an Oct 2024 investor entry; details gated or obfuscated.
Dealroom lists Mar 2025 investor entries including CTP Support Holstein, ACap, CS Erste Beteiligungs.
“Multiple investors reported across late-2024 to early-2025 with at least one named lead investor (Thomas Pötzsch) for a Series A”
Willkommen bei TCC! Die TCC GmbH wurde im Jahr 2020 in Hamburg gegründet. Heute arbeiten bei uns über 50 engagierte Mitarbeiter:innen an einem gemeinsamen Ziel: die medizinische Versorgung durch digitale Innovationen nachhaltig zu verbessern. Als zertifizierter Hersteller von Software als Medizinprodukt und Anbieter medizinischer Services entwickeln wir eine KI-gestützte Telemedizinplattform, die sektorenübergreifende Versorgung ermöglicht und medizinisches Fachpersonal gezielt unterstützt. Unsere Lösungen verbinden klinische Expertise mit technologischer Exzellenz – für eine datengestützte, qualitätsorientierte und zukunftsfähige Medizin.
Zur Bewerbung schreibe bitte eine E-Mail an hr@tcc-clinicalsolutions.de. Wir freuen uns über Deinen Lebenslauf sowie Dein Anschreiben in PDF-Format in Deutsch.
Bewirb Dich jetzt und werde Teil unseres Teams!
Bei Fragen steht Dir unsere Personalabteilung gerne unter 040-239 68 33 30 zur Verfügung.